Michael Adam

Michael Adam

Company: GlaxoSmithKline

Job title: Investigator


Michael Adam has worked as a principal investigator with over 6 years industry experience in preclinical through to phase 2 development of small molecules and biologics, with a current focus on innate immunity, working as the biology lead for a TLR4 agonist program. 


Live Q&A 5:00 pm

Read more

day: Online Conference

Dose Regimen Considerations to Optimize TLR Agonist Therapy for Cancer: How, How much, How often, How long? 4:00 pm

•These are central questions for the optimization of TLR (and STING) agonists for the treatment of cancer. What can we learn from emerging clinical data and applications of these agents in other contexts outside of cancer? • Can a therapeutic index be achieved with IV administration of a TLR agonist? • How can PK-PD and…Read more

day: Online Conference

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.